BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Orthopedic Splints Market – Forecast to 2030,’ thoroughly examines the Orthopedic Splints industry to provide essential data & information for the targeted readers.

Edgewise Therapeutics, Inc. announced the pricing of its upsized underwritten public offering of 11,627,907 shares of its common stock at a price to the public of $10.32 per share.

On Wednesday morning, September 14th, two dozen advocates from AIDS Healthcare Foundation, the largest global AIDS organization, and its affiliates, Iris House and ACQC will spearhead a protest targeting Gilead Sciences during the annual Baird Global Healthcare Investor Conference being held at the Intercontinental – New York Barclay in New York City.

AIDS Healthcare Foundation (AHF), which has been sharply critical of Los Angeles County leadership in its handling of monkeypox, is now expanding its call on government and public health officials everywhere to greatly scale up vaccine rollout and prevention messaging nationwide.

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the poster presentation of further clinical validation data for PurIST℠, a novel RNA-expression test, in collaboration with Tempus.

The latest market analysis report published by Reports and Data, titled ‘Global Marfan Syndrome Market – Forecast to 2030,’ thoroughly examines the Marfan Syndrome industry to provide essential data & information for the targeted readers.

Olympus Corporation announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals for endoscopic procedures across multiple medical disciplines.